The Role of PET/CT in Breast Cancer.

PET breast cancer

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
06 Feb 2023
Historique:
received: 12 12 2022
revised: 05 01 2023
accepted: 16 01 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 26 2 2023
Statut: epublish

Résumé

Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer worldwide, with an estimated 2.3 million new cases (11.7%), followed by lung cancer (11.4%) The current literature and the National Comprehensive Cancer Network (NCCN) guidelines state that

Identifiants

pubmed: 36832085
pii: diagnostics13040597
doi: 10.3390/diagnostics13040597
pmc: PMC9955497
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Curr Treat Options Oncol. 2018 Apr 11;19(5):21
pubmed: 29644491
Breast Cancer (Auckl). 2020 Dec 16;14:1178223420980377
pubmed: 33402827
AJR Am J Roentgenol. 2019 Aug;213(2):254-265
pubmed: 31063423
Semin Nucl Med. 2022 Sep;52(5):520-530
pubmed: 35525631
EJNMMI Res. 2020 Apr 25;10(1):42
pubmed: 32335823
Eur J Cancer. 2013 May;49(7):1539-45
pubmed: 23369464
Nucl Med Rev Cent East Eur. 2020;23(1):32-35
pubmed: 32779172
J Nucl Med. 2017 Dec;58(12):1906-1912
pubmed: 28912144
J Nucl Med. 2016 Feb;57 Suppl 1:27S-33S
pubmed: 26834098
Asian Pac J Cancer Prev. 2016;17(S3):43-6
pubmed: 27165206
Breast Cancer Res Treat. 2010 Aug;123(1):281-90
pubmed: 20140703
Ann Nucl Med. 2021 Jun;35(6):744-752
pubmed: 33934311
PET Clin. 2018 Jul;13(3):437-444
pubmed: 30100081
Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):23-36
pubmed: 20871992
J Nucl Med. 2018 Sep;59(9):1415-1422
pubmed: 29626119
Nucl Med Commun. 2016 Nov;37(11):1180-8
pubmed: 27428888
Diagnostics (Basel). 2015 Mar 16;5(1):61-83
pubmed: 26854143
Biochim Biophys Acta Mol Basis Dis. 2022 Nov 1;1868(11):166520
pubmed: 35985446
J Nucl Med. 2018 Sep;59(9):1423-1429
pubmed: 29626120
Int J Cancer. 2017 Feb 15;140(4):938-947
pubmed: 27813061
Diagnostics (Basel). 2021 Oct 21;11(11):
pubmed: 34829301
Ann Oncol. 2013 Sep;24(9):2206-23
pubmed: 23917950
EJNMMI Res. 2018 Sep 6;8(1):90
pubmed: 30191351
Eur J Cancer. 2014 Jul;50(11):1864-71
pubmed: 24841218
Clin Breast Cancer. 2000 Jul;1(2):156-61; discussion 162-3
pubmed: 11899654
Proc Natl Acad Sci U S A. 1990 Sep;87(18):7235-9
pubmed: 2402505
Genes Dev. 2016 May 1;30(9):1002-19
pubmed: 27151975
Eur J Gynaecol Oncol. 2015;36(6):672-6
pubmed: 26775349
J Natl Compr Canc Netw. 2020 Sep;18(9):1240-1246
pubmed: 32886897
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Ann Nucl Med. 2019 Jun;33(6):404-413
pubmed: 30877560
Eur J Med Chem. 2022 Nov 15;242:114690
pubmed: 36041258
J Nucl Med. 2018 Jan;59(1):38-43
pubmed: 28637802
Lancet. 2011 Nov 19;378(9805):1812-23
pubmed: 22098854
Biomed Res Int. 2015;2015:489021
pubmed: 25879025
Oncogene. 2017 Mar 2;36(9):1211-1222
pubmed: 27669438
Cells. 2020 Oct 21;9(10):
pubmed: 33096754
Blood. 2005 Sep 15;106(6):1901-10
pubmed: 15890683
Lancet Oncol. 2018 Jun;19(6):812-824
pubmed: 29706375
Cancer Lett. 2018 Apr 1;418:196-203
pubmed: 29317253
Semin Nucl Med. 2001 Jan;31(1):28-49
pubmed: 11200203
Breast Cancer Res Treat. 2016 Jan;155(2):273-84
pubmed: 26791520
EJNMMI Radiopharm Chem. 2021 Aug 21;6(1):26
pubmed: 34417894
J Natl Compr Canc Netw. 2022 Jun;20(6):691-722
pubmed: 35714673
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1482-3
pubmed: 25931036
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2833-2843
pubmed: 34893920
J Clin Oncol. 2006 Jul 1;24(19):3026-31
pubmed: 16717291
J Med Imaging Radiat Oncol. 2022 Sep;66(6):731-737
pubmed: 34676675
Jpn J Radiol. 2016 Mar;34(3):167-80
pubmed: 26733340
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):689-694
pubmed: 27822700
Breast Cancer Res. 2020 Jun 9;22(1):61
pubmed: 32517735
Tohoku J Exp Med. 2018;245(1):13-19
pubmed: 29731479
PET Clin. 2015 Apr;10(2):159-95
pubmed: 25829085
Clin Cancer Res. 2017 Jan 15;23(2):407-415
pubmed: 27342400
Clin Nucl Med. 2017 May;42(5):335-340
pubmed: 28263210
J Nucl Med. 2022 Mar;63(3):415-423
pubmed: 34168013
Nat Commun. 2021 Feb 2;12(1):733
pubmed: 33531464
PLoS One. 2016 Dec 19;11(12):e0168248
pubmed: 27992512
Eur J Cancer. 2000 Mar;36(4):476-82
pubmed: 10717523
Theranostics. 2013;3(1):76-84
pubmed: 23382787
Proteomics Clin Appl. 2014 Jun;8(5-6):454-63
pubmed: 24470260
Lancet. 2021 May 8;397(10286):1750-1769
pubmed: 33812473
Theranostics. 2016 Jun 19;6(10):1641-50
pubmed: 27446498
N Engl J Med. 2003 Aug 7;349(6):546-53
pubmed: 12904519
World J Nucl Med. 2022 Apr 30;21(1):1-8
pubmed: 35502272
J Control Release. 2021 Jun 10;334:248-262
pubmed: 33915224
Nucl Med Mol Imaging. 2019 Oct;53(5):313-319
pubmed: 31723360
J Nucl Med. 2018 Dec;59(12):1809-1816
pubmed: 29700127
J Int Med Res. 2018 Aug;46(8):3138-3148
pubmed: 29781364
Breast Cancer Res. 2018 Jul 27;20(1):78
pubmed: 30053906
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
Eur J Cancer. 2012 Dec;48(18):3499-513
pubmed: 22658807
J Clin Med. 2022 Mar 30;11(7):
pubmed: 35407526
J Surg Res. 2009 Sep;156(1):26-31
pubmed: 19631337
Jpn J Radiol. 2014 Feb;32(2):59-68
pubmed: 24337913
J BUON. 2015 Sep-Oct;20(5):1282-6
pubmed: 26537076
Ann Nucl Med. 2021 Dec;35(12):1321-1331
pubmed: 34436740
Asia Ocean J Nucl Med Biol. 2019 Winter;7(1):13-21
pubmed: 30705907
Surg Oncol. 2013 Jun;22(2):86-91
pubmed: 23726506
Breast Cancer Res Treat. 2020 Jun;181(2):383-390
pubmed: 32318957
Mol Imaging Biol. 2019 Feb;21(1):1-10
pubmed: 29516387
In Vivo. 2021 Jan-Feb;35(1):23-30
pubmed: 33402446
J Nucl Med. 2009 Oct;50(10):1655-65
pubmed: 19759099
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
Nuklearmedizin. 2015;54(4):163-72
pubmed: 26165806
J Nucl Med. 2012 Feb;53(2):182-90
pubmed: 22241912
J Nucl Med. 2022 Jan;63(1):22-28
pubmed: 34049982
Br J Cancer. 2014 Jun 10;110(12):2847-54
pubmed: 24832174
Technol Cancer Res Treat. 2005 Feb;4(1):55-60
pubmed: 15649088
Drug Des Devel Ther. 2015 Aug 28;9:4953-64
pubmed: 26356032
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):942-944
pubmed: 32783111
Proc (Bayl Univ Med Cent). 2013 Jul;26(3):314-9
pubmed: 23814402
Surg Oncol. 2013 Jun;22(2):139-43
pubmed: 23566435
Biomacromolecules. 2017 Jun 12;18(6):1793-1802
pubmed: 28445650
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):134-142
pubmed: 32424485
Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):262-70
pubmed: 22065013
Cancers (Basel). 2022 Apr 23;14(9):
pubmed: 35565232
Mol Imaging Biol. 2016 Dec;18(6):952-959
pubmed: 27146421
Clin Nucl Med. 2021 Apr 1;46(4):271-282
pubmed: 33651022
EJNMMI Res. 2020 Apr 19;10(1):40
pubmed: 32307594
Adv Clin Exp Med. 2016 Mar-Apr;25(2):377-82
pubmed: 27627573
ACS Med Chem Lett. 2013 Mar 18;4(5):491-6
pubmed: 24900696

Auteurs

Bawinile Hadebe (B)

Department of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Private Bag X54001, Durban 4001, South Africa.
Inkosi Albert Luthuli Central Hospital, Durban 4001, South Africa.

Lerwine Harry (L)

Department of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Private Bag X54001, Durban 4001, South Africa.
Inkosi Albert Luthuli Central Hospital, Durban 4001, South Africa.

Tasmeera Ebrahim (T)

Department of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Private Bag X54001, Durban 4001, South Africa.
Inkosi Albert Luthuli Central Hospital, Durban 4001, South Africa.

Venesen Pillay (V)

Department of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Private Bag X54001, Durban 4001, South Africa.
Inkosi Albert Luthuli Central Hospital, Durban 4001, South Africa.

Mariza Vorster (M)

Department of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Private Bag X54001, Durban 4001, South Africa.
Inkosi Albert Luthuli Central Hospital, Durban 4001, South Africa.

Classifications MeSH